Deleterious effects of long-term single-chamber ventricular pacing in patients with sick sinus syndrome: the hidden benefits of dual-chamber pacing

Pacemaker Center, Newark Beth Israel Medical Center, New Jersey 07112.

Nine hundred fifty patients who received three modes of primary pacemaker systems (581 dual-chamber universal [DDD], 84 atrioventricular-sequential ventricular-inhibited [DVI] and 285 ventricular-inhibited [VVI]) over 12 years were studied retrospectively to determine the effect of pacing mode on patient longevity and the subsequent development of chronic atrial fibrillation or flutter. All patients were followed up continuously for 7 to 8 years. Patients were classified according to indication for permanent pacing (sick sinus syndrome or other indication), age at pacemaker implantation (less than or equal to 70 or greater than 70 years) and history of atrial tachyarrhythmia. Fourteen percent of patients developed atrial fibrillation at some time during the study period. Of those, 4% had a DDD pacemaker, 8% had a DVI pacemaker and 19% had a VVI pacemaker. At 7 years, atrial fibrillation was significantly more frequent in the VVI group than in the DDD and DVI groups. In patients with sick sinus syndrome, the incidence rate was even higher in the VVI group but approximately the same in the DDD and DVI groups. Patients in the VVI and DVI groups who had had previous atrial tachyarrhythmia had a significantly higher incidence of atrial fibrillation at 7 years than did those in the DDD group. During the entire period there were 130 deaths in the study group, including 22% of patients with a DDD pacemaker, 38% of those with a DVI pacemaker and 50% of those with a VVI pacemaker. Patient survival at 7 years was lower in the VVI group than in the DDD or DVI groups.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				K. Kaszala, J. F. Huizar, and K. A. Ellenbogen Contemporary Pacemakers: What the Primary Care Physician Needs to Know Mayo Clin. Proc., October 1, 2008; 83(10): 1170 - 1186. [Abstract] [Full Text] [PDF]

				Z. Goldberger and R. Lampert Implantable Cardioverter-Defibrillators: Expanding Indications and Technologies JAMA, February 15, 2006; 295(7): 809 - 818. [Abstract] [Full Text] [PDF]

				C. W. Israel The role of pacing mode in the development of atrial fibrillation. Europace, February 1, 2006; 8(2): 89 - 95. [Abstract] [Full Text] [PDF]

				F. Walker, S. C. Siu, S. Woods, D. A. Cameron, G. D. Webb, and L. Harris Long-Term outcomes of cardiac pacing in adults with congenital heart disease J. Am. Coll. Cardiol., May 19, 2004; 43(10): 1894 - 1901. [Abstract] [Full Text] [PDF]

				G. A. Lamas, K. A. Ellenbogen, and With the Assistance of Charles H. Hennekens, MD, D Evidence Base for Pacemaker Mode Selection: From Physiology to Randomized Trials Circulation, February 3, 2004; 109(4): 443 - 451. [Full Text] [PDF]

				A. Quesada, J.ús Almendral, F. Arribas, R. Ricci, C. Wolpert, P. Adragao, E. Cobo, X. Navarro, and on behalf DATAS investigators The DATAS rationale and design: a controlled, randomized trial to assess the clinical benefit of dual chamber (DDED) defibrillator Europace, January 1, 2004; 6(2): 142 - 150. [Abstract] [Full Text] [PDF]

				H. Masumoto, Y. Ueda, R. Kato, A. Usui, T. Maseki, Y. Takagi, and M. Usui Long-term clinical performance of AAI pacing in patients with sick sinus syndrome: a comparison with dual-chamber pacing Europace, January 1, 2004; 6(5): 444 - 450. [Abstract] [Full Text] [PDF]

				M. D. Carlson, J. Ip, J. Messenger, S. Beau, S. Kalbfleisch, P. Gervais, D. A. Cameron, A. Duran, J. Val-Mejias, J. Mackall, et al. A new pacemaker algorithm for the treatment of atrial fibrillation: Results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT) J. Am. Coll. Cardiol., August 20, 2003; 42(4): 627 - 633. [Abstract] [Full Text] [PDF]

				M. Santini and R. Ricci Atrial fibrillation and heart failure Europace, January 1, 2003; 5(s1): S55 - S59. [Full Text] [PDF]

				J. M. Cooper, M. S. Katcher, and M. V. Orlov Implantable Devices for the Treatment of Atrial Fibrillation N. Engl. J. Med., June 27, 2002; 346(26): 2062 - 2068. [Full Text] [PDF]

				G. A. Lamas, K. L. Lee, M. O. Sweeney, R. Silverman, A. Leon, R. Yee, R. A. Marinchak, G. Flaker, E. Schron, E. J. Orav, et al. Ventricular Pacing or Dual-Chamber Pacing for Sinus-Node Dysfunction N. Engl. J. Med., June 13, 2002; 346(24): 1854 - 1862. [Abstract] [Full Text] [PDF]

				L. Padeletti, P. Pieragnoli, C. Ciapetti, A. Colefa, N. Musilli, M.C. Porciani, A. Michelucci, and G.F. Gensini Prevention of paroxysmal atrial fibrillation by permanent septal atrial pacing: long-term follow up Eur. Heart J. Suppl., November 1, 2001; 3(suppl_P): P2 - P6. [Abstract] [PDF]

				G. Boriani, M. Biffi, L. Padeletti, A. Sparnpinato, G. Luca Botto, C. Pignalberi, A. Grammatico, D.A. Hettrick, F. De Seta, and A. Branzi Effects of consistent atrial pacing and atrial rate stabilization - two pacing algorithms to suppress recurrent paroxysmal atrial fibrillation in brady-tachy syndrome Eur. Heart J. Suppl., November 1, 2001; 3(suppl_P): P7 - P15. [Abstract] [PDF]

				A. C. Skanes, A. D. Krahn, R. Yee, G. J. Klein, S. J. Connolly, C. R. Kerr, M. Gent, K. E. Thorpe, R. S. Roberts, and for the CTOPP Investigators Progression to chronic atrial fibrillation after pacing: the Canadian Trial of Physiologic Pacing J. Am. Coll. Cardiol., July 1, 2001; 38(1): 167 - 172. [Abstract] [Full Text] [PDF]

				K. J. Ward, J. E. Willett, C. Bucknall, J. S. Gill, and K. Kamalvand Atrial arrhythmia suppression by atrial overdrive pacing: pacemaker Holter assessment Europace, January 1, 2001; 3(2): 108 - 114. [Abstract] [PDF]

				S. J. Connolly, C. R. Kerr, M. Gent, R. S. Roberts, S. Yusuf, A. M. Gillis, M. H. Sami, M. Talajic, A. S.L. Tang, G. J. Klein, et al. Effects of Physiologic Pacing versus Ventricular Pacing on the Risk of Stroke and Death Due to Cardiovascular Causes N. Engl. J. Med., May 11, 2000; 342(19): 1385 - 1391. [Abstract] [Full Text] [PDF]

				M. K. Chung, R. S. Augostini, C. R. Asher, D. P. Pool, T. A. Grady, M. Zikri, S. M. Buehner, M. Weinstock, and P. M. McCarthy Ineffectiveness and potential proarrhythmia of atrial pacing for atrial fibrillation prevention after coronary artery bypass grafting Ann. Thorac. Surg., April 1, 2000; 69(4): 1057 - 1063. [Abstract] [Full Text] [PDF]

				A. M. Gillis, D. G. Wyse, S. J. Connolly, M. Dubuc, F. Philippon, R. Yee, P. Lacombe, M. S. Rose, and C. D. Kerr Atrial Pacing Periablation for Prevention of Paroxysmal Atrial Fibrillation Circulation, May 18, 1999; 99(19): 2553 - 2558. [Abstract] [Full Text] [PDF]

				A. Jahangir, W.-K. Shen, S. A. Neubauer, D. J. Ballard, S. C. Hammill, D. O. Hodge, C. M. Lohse, B. J. Gersh, and D. L. Hayes Relation between mode of pacing and long-term survival in the very elderly J. Am. Coll. Cardiol., April 1, 1999; 33(5): 1208 - 1216. [Abstract] [Full Text] [PDF]

				J. M. McComb and G. M. Gribbin Chronic atrial fibrillation in patients with paroxysmal atrial fibrillation, atrioventricular node ablation and pacemakers: Determinants and treatment Europace, January 1, 1999; 1(1): 30 - 34. [Abstract] [PDF]

				A. M. Gillis The Atrial Pacing Peri-ablation for Paroxysmal Atrial Fibrillation (PA3) Study: Rationale and study design Europace, January 1, 1999; 1(1): 40 - 42. [Abstract] [PDF]

				H J MARSHALL, M D GAMMAGE, and M J GRIFFITH AAI pacing for sick sinus syndrome: first choice on all counts Heart, October 1, 1998; 80(4): 315 - 316. [Full Text]

				H. R. Andersen, J. C. Nielsen, P. E. B. Thomsen, L. Thuesen, T. Vesterlund, A. K. Pedersen, and P. T. Mortensen Atrioventricular Conduction During Long-Term Follow-Up of Patients With Sick Sinus Syndrome Circulation, September 29, 1998; 98(13): 1315 - 1321. [Abstract] [Full Text] [PDF]

				G M Gribbin, J P Bourke, and J M McComb Predictors of atrial rhythm after atrioventricular node ablation for the treatment of paroxysmal atrial arrhythmias Heart, June 1, 1998; 79(6): 548 - 553. [Abstract] [Full Text]

				G. A. Lamas, E. J. Orav, B. S. Stambler, K. A. Ellenbogen, E. B. Sgarbossa, S. K. S. Huang, R. A. Marinchak, N.A. M. Estes, G. F. Mitchell, E. H. Lieberman, et al. Quality of Life and Clinical Outcomes in Elderly Patients Treated with Ventricular Pacing as Compared with Dual-Chamber Pacing N. Engl. J. Med., April 16, 1998; 338(16): 1097 - 1104. [Abstract] [Full Text] [PDF]

				J. W. Mason and M. A. Hlatky Do Patients Prefer Physiologic Pacing? N. Engl. J. Med., April 16, 1998; 338(16): 1146 - 1148. [Full Text]

				D J R Hildick-Smith, M D Lowe, S A Newell, P M Schofield, L M Shapiro, D L Stone, A A Grace, and M C Petch Ventricular pacemaker upgrade: experience, complications and recommendations Heart, April 1, 1998; 79(4): 383 - 387. [Abstract] [Full Text]

				C.-P. Lau, H.-F. Tse, and G. Cheng Effects of atrioventricular asynchrony on platelet activation: implication of thromboembolism in paced patients Heart, October 1, 1997; 78(4): 358 - 363. [Abstract] [Full Text] [PDF]

				P. Papageorgiou, F. Anselme, C. J. H. J. Kirchhof, K. Monahan, C. A. F. Rasmussen, L. M. Epstein, and M. E. Josephson Coronary Sinus Pacing Prevents Induction of Atrial Fibrillation Circulation, September 16, 1997; 96(6): 1893 - 1898. [Abstract] [Full Text]

				P. Alboni, C. Menozzi, M. Brignole, N. Paparella, G. Gaggioli, G. Lolli, and R. Cappato Effects of Permanent Pacemaker and Oral Theophylline in Sick Sinus Syndrome : The THEOPACE Study: A Randomized Controlled Trial Circulation, July 1, 1997; 96(1): 260 - 266. [Abstract] [Full Text]

				G. A. Lamas, C. L. Pashos, S.-L. T. Normand, and B. McNeil Permanent Pacemaker Selection and Subsequent Survival in Elderly Medicare Pacemaker Recipients Circulation, February 15, 1995; 91(4): 1063 - 1069. [Abstract] [Full Text]

				ARE DUAL-CHAMBER PACEMAKERS SAFER Journal Watch (General), June 16, 1992; 1992(616): 6 - 6. [Full Text]